Comparison of CT and 18F-FDG PET for Detecting Peritoneal Metastasis on the Preoperative Evaluation for Gastric Carcinoma by 源�湲고솴 et al.
Korean J Radiol 7(4), December 2006 249
Comparison of CT and 18F-FDG PET for
Detecting Peritoneal Metastasis on the
Preoperative Evaluation for Gastric
Carcinoma
Objective: The aim of our study was to compare the accuracy of CT and 18F-
FDG PET for detecting peritoneal metastasis in patients with gastric carcinoma.
Materials and Methods: One-hundred-twelve patients who underwent a histo-
logic confirmative exam or treatment (laparotomy, n = 107; diagnostic
laparoscopy, n = 4; peritoneal washing cytology, n = 1) were retrospectively
enrolled. All the patients underwent CT and 18F-FDG PET scanning for their pre-
operative evaluation. The sensitivities, specificities and accuracies of CT and 18F-
FDG PET imaging for the detection of peritoneal metastasis were calculated and
then compared using Fisher’s exact probability test (p < 0.05), on the basis of the
original preoperative reports. In addition, two board-certified radiologists and two
board-certified nuclear medicine physicians independently reviewed the CT and
PET scans, respectively. A receiver-operating characteristic curve analysis was
performed to compare the diagnostic performance of CT and 18F-FDG PET imag-
ing for detecting peritoneal metastasis. 
Results: Based on the original preoperative reports, CT and 18F-FDG PET
showed sensitivities of 76.5% and 35.3% (p = 0.037), specificities of 91.6% and
98.9% (p = 0.035), respectively, and equal accuracies of 89.3% (p = 1.0). The
receptor operating characteristics curve analysis showed a significantly higher
diagnostic performance for CT (Az = 0.878) than for PET (Az = 0.686) (p =
0.004). The interobserver agreement for detecting peritoneal metastasis was
good ( value = 0.684) for CT and moderate ( value = 0.460) for PET.
Conclusion: For the detection of peritoneal metastasis, CT was more sensitive
and showed a higher diagnostic performance than PET, although CT had a rela-
tively lower specificity than did PET. 
btaining preoperative knowledge on peritoneal metastasis in gastric
adenocarcinoma patients is important for planning the operative
procedure. This allows the surgeon to decide whether the surgery is likely
to be potentially curative or palliative in nature, and it helps avoid any unnecessary
laparotomy procedures. However, detecting peritoneal metastasis is difficult because
the imaging modalities can vary in their ability to detect tumor deposits, and laparo-
scopic techniques are limited by sampling error (1). CT is known to be the first choice
as a preoperative modality for detecting peritoneal metastasis. However, it has been
reported that CT has a limited capacity for demonstrating peritoneal metastases (2 4)
and its sensitivity can vary: this depends on such factors as the size, site and morphol-
ogy of tumor deposits, the presence of ascites, the paucity of intra-abdominal fat, the
adequacy of bowel opacification and the concomitant use of peritoneography (5 7). 
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18F-FDG PET scan has recently been recognized as a
useful diagnostic technique in clinical oncology (8, 9).
However, experience with using 18F-FDG PET scanning for
detecting peritoneal metastasis is very limited. A few
studies have reported that 18F-FDG PET demonstrates
superior sensitivity to CT for evaluating peritoneal
metastasis in a various abdominal malignancies (10 12).
However, there is scant comparison data regarding detect-
ing peritoneal metastasis by CT and 18F-FDG PET for the
preoperative evaluation of gastric adenocarcinoma. The
purpose of our study was to compare the accuracy of CT
and 18F-FDG PET for detecting peritoneal metastasis in the
patients suffering with gastric carcinoma. 
Materials and Methods
Patients
From January 2003 to January 2004, 124 patients were
referred to our hospital because of their diagnosed gastric
carcinoma, and they underwent CT and 18F-FDG PET scans
for the pretreatment evaluation. The radiologic, surgical,
pathologic and clinical reports on these 124 patients were
retrieved from an institution-wide patient database system.
Our institutional review board approved all aspects of this
retrospective study and did not require an informed
consent from any of the patients whose records were
included in our study. Twelve of the 124 patients did not
undergo surgery or confirmative histologic examination.
These cases were excluded from this analysis because any
positive or negative outcome about peritoneal metastasis
could not be confirmatively determined. The remaining
112 patients (73 men and 39 women, mean age: 55.5
years, age range: 16 80 years), who underwent histologic
confirmative exam or treatment (laparotomy: n = 107,
diagnostic laparoscopy: n = 4, and peritoneal washing
cytology: n = 1), were enrolled in our study. Through
conducting a review of the surgical or pathologic reports
for confirming the presence or absence of peritoneal
metastasis, 95 patients were without peritoneal metastasis
based on the laparotomy findings. However, peritoneal
metastasis was histologically confirmed in 17 patients
(10.7%) (12 men and 5 women, mean age: 51.4 years, age
range: 32 74 years). In the cases with peritoneal metasta-
sis, the types of cell differentiation of the primary lesions
were as follows: moderate differentiation: n = 2, mixed
type of moderate and poor differentiation: n = 2, signet cell
differentiation: n = 4, poor differentiation: n = 9.
CT Technique
All the patients included in the study underwent single-
section spiral CT (HiSpeed CT/I, GE Medical Systems,
Milwaukee, WI) or multi-detector CT scanning (four-
detector row; Lightspeed Plus, GE Medical Systems,
Milwaukee, WI or sixteen-detector row; Sensation 16,
Siemens, Erlangen, Germany), according to an established
protocol. Each patient fasted for six hours before undergo-
ing CT, they drank 750 1000 mL of pure tap water
immediately before scanning and they routinely
underwent CT scans in a prone position for achieving
gastric distention. Neither anticholinergic agents nor
glucagon was administered. A 60% iodinated contrast
material (Iopromide [Ultravist]; Schering, Berlin, diatri-
zoate meglumine [Hypaque] or iohexol [Omnipaque 300];
Nycomed Amersham, Princeton, NJ) was administered
intravenously at a rate of 2 4 mL/sec by using an
automatic power injector with a volume of 2 mL/kg up to a
maximum volume of 150 mL/kg. CT scans were obtained
at approximately 70 seconds (the parenchymal phase) after
initiating the contrast material injection. The abdomen and
pelvis, from the level of the hepatic dome to the ischial
tuberosities, were scanned with 0.75 7.0 mm section
collimation, a pitch of 1.0 1.5, and 3.0 7.0 mm of
reconstruction thickness. The transverse images were
reconstructed with a soft-tissue algorithm.
18F-FDG PET Technique
18F-FDG PET was performed in all the patients within a
month of the CT study (range: 0 28 days, mean: 9.3
days). The patients fasted for at least four hours before the
intravenous injection of 370 555 MBq of FDG. Scanning
was initiated 60 min after administration of the tracer. The
images were obtained on either a GE advance PET scanner
(GE advance, GE Medical Systems, Milwaukee, WI) or a
Philips Allegro PET system (Allegro, Philips-ADAC
medical systems, Cleveland, OH). The intrinsic spatial
resolution of these systems was approximately 5 mm (full-
width at half-maximum) in the center of the field of view.
Sequential emission scans were acquired from the neck to
the proximal thighs. Transmission scans, with using Ge-68
for the GE advance system or Cs-137 point sources for the
Allegro system, were obtained at the end of the emission
scans in order to correct for non-uniform attenuation. The
images were reconstructed using order subset expectation
maximization (OSEM) for the GE advance system or a low
action maximal likelihood algorithm (RAMLA) for the
Allegro system.
Data Analysis on the Basis of the Original
Preoperative CT and PET Imaging Reports 
The original preoperative CT and PET reports for the
112 patients were reviewed. Three experienced gastroin-
testinal radiologists were involved in the preoperative
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diagnoses using CT; the radiologists’ experience ranged
from three to 15 years. Two experienced nuclear medicine
physicians were also involved in the preoperative
diagnoses using PET; the physicians’ experiences were five
and 15 years, respectively. In the cases in which the
interpreters identified or suspected peritoneal metastasis
on the original preoperative reports, the study coordinator
considered those cases to be positive for the presence of
peritoneal metastasis. We compared the presence or
absence of peritoneal metastasis, according to the CT and
PET imaging, with the surgical and histopathologic
standards of reference for each patient; we then
determined the number of true-positive, true-negative,
false-positive and false-negative imaging results. The
sensitivity, specificity and accuracy of each imaging
modality were calculated and compared using Fisher’s
exact probability test (p < 0.05).
Receiver-operating Characteristic Curve Analysis of the
Diagnostic Performance of CT versus PET in Detecting
Peritoneal Metastasis
We performed receiver-operating characteristic curve
(ROC) analysis to compare the diagnostic performance of
CT and PET imaging for detecting peritoneal metastasis.
Among 17 patients (12 men and 5 women, mean age: 51.4
years, age range: 32 74 years) with histologically proven
peritoneal metastasis, 16 patients were included in the
positive group for the ROC analysis. One patient was
excluded because the CT imaging data was not available.
Furthermore, among the 95 patients who showed no
peritoneal abnormalities on the surgical findings, the study
coordinator selected 22 patients to be in the negative
group (12 men and 10 women, mean age: 55.5 years, age
range: 16 72 years) since they showed negative findings
on the six month follow-up CT. The six month follow-up
criteria were used to exclude the hidden peritoneal
metastasis and to control the sample size for the ROC
analysis. Two board-certified radiologists, who had sub-
specialist expertise in abdominal imaging, independently
reviewed the CT images on a high-resolution computer
screen; the reviewer’s experiences were three and five
years, respectively. The PET images were also reviewed by
two board-certified nuclear medicine physicians; the
reviewer’s experiences were two and three years, respec-
tively. All the reviewers were unaware of the patients’
clinical or pathologic findings about peritoneal metastasis.
They rated the likelihood of peritoneal metastases on a
five point scale as follows: 1, definitely absent; 2, probably
absent; 3, indeterminate; 4, probably present; and 5,
definitely present. For the CT images, the reviewers used
the same criteria for the identification of peritoneal
metastasis, that is, the presence of a nodular, plaque-like or
infiltrative soft-tissue lesion in the peritoneal fat or on the
peritoneal surface (13, 14) (Figs. 1A, 2A, 3A). The
presence of ascites, parietal peritoneal thickening or
enhancement, and small-bowel wall thickening or distor-
tion were also used as references since these findings have
been described as ancillary signs of peritoneal malignancy
(15, 16). On the PET images, the reviewers regarded
certain focal or diffuse metabolic abnormalities in the
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Fig. 1. A 62-year-old man with poorly differentiated adenocarcinoma of the stomach.
A. The transverse contrast enhanced CT scan shows multifocal peritoneal implants
in the omentum (arrows). 
B. The PET image shows the diffuse FDG uptake that obscures the visceral outlines
in the peritoneal cavity (arrows). Peritoneal metastasis was confirmed by diagnostic
laparoscopy.
A
B
abdomen or pelvis as signs of peritoneal metastasis (Fig.
1B). Discrete foci of increased FDG metabolism located
either randomly and anteriorly within the abdomen or
dependently within the pelvis, which were unrelated to
solid viscera or nodal stations, were used as indicators of
peritoneal metastasis (12) (Fig. 2B). The pattern of diffuse,
low-grade glucose hyper-metabolism spreading uniformly
throughout the abdomen and pelvis and obscuring the
visceral outlines, and particularly the normal serpiginous
pattern of the large and small bowel and the physiologic
hepatic and splenic uptake, was also considered to be a
sign of peritoneal metastasis (12, 17). 
Statistical Analysis for ROC Analysis
Before the ROC analysis, the interobserver agreement
on the image interpretation for the CT and PET imaging
was assessed with the weighted statistic for establishing
their reliability in our study. The degrees of agreement
were categorized as follows: values of 0.00 0.20 were
considered to indicate poor agreement, values of 0.21
0.40 were fair agreement, values of 0.41 0.60 were
moderate agreement, values of 0.61 0.80 were good
agreement and values of 0.81 1.00 were excellent
agreement (18).
To represent the performance of all the observers as a
group, we plotted the receiver operating characteristic
curves for the composite data assigned by each observer
for the CT and PET imaging, as was demonstrated in
previously published articles (19, 20). With the use of ROC
evaluation software (MedCalc Software, Mariakerke
Belgium), the diagnostic accuracy of each imaging
technique was determined by calculating the area under
the ROC curve (Az). The differences between the ROC
curves were tested for their significance (p < 0.05) with
using the two-tailed area test for paired data (a univariate z
score test on the difference between the areas under the
ROC curves with the null hypothesis being that the data
sets arose from binomial ROC curves with equal areas
beneath them). 
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Fig. 2. A 60-year-old man with poorly differentiated adenocarcinoma of the stomach.
A. The transverse contrast enhanced CT scan shows a peritoneal implant (arrow) in
the right paracolic gutter. 
B. The PET image shows a discrete focus (arrow) of increased FDG metabolism in
the same location. Peritoneal metastasis was confirmed by laparotomy.
A
B
Table 1. Detection of Peritoneal Metastasis on CT and PET Imaging
Examination TP* TN* FP* FN* Sensitivity Specificity Accuracy
CT 13 87 8 04 76.5 91.6 89.3
PET 06 94 1 11 35.3 98.9 89.3
Note. * Data are the numbers of patients out of a total of 112 patients with false negative (FN), false-positive (FP), true-negative (TN), and true-positive
(TP) findings of peritoneal metastasis.
The sensitivity, specificity and accuracy values are cited as percentages.
RESULTS
Data Analysis on the Basis of the Original
Preoperative Reports
The number of true-positive, true-negative, false-positive
and false-negative cases, as well as the sensitivity,
specificity and accuracy of CT and PET imaging for the
diagnosis of peritoneal metastasis, are listed in Table 1. The
sensitivities of CT and PET for detecting peritoneal
metastasis were 76.5% (13 of 17 patients, 95% confidence
interval: 53 and 90) and 35.3% (6 of 17 patients, 95%
confidence interval: 17 and 59) (p = 0.037), respectively
(Fig. 3). The specificities of CT and PET were 91.6% (87 of
95 patients, 95% confidence interval: 84 and 96) and
98.9% (94 of 95 patients, 95% confidence interval: 94 and
100) (p = 0.035), respectively (Fig. 4). The accuracies of
CT and PET were equal (89.3% each) (p = 1.0).
Receiver-operating Characteristic Curve Analysis
The calculated Az values from each reviewer for CT and
PET are shown in Table 2. The composite ROC curves
formed on the basis of the pooled data from the two
observers for the CT and PET, respectively, are shown in
Figure 5. The accuracy of CT (Az = 0.878) was signifi-
cantly superior compared with the accuracy of PET (Az =
0.686) for detecting peritoneal metastasis (p = 0.004). The
interobserver agreement for detecting peritoneal metasta-
sis was good ( value = 0.684) for CT and moderate (
value = 0.460) for PET. The Kappa value tended to be
higher for the CT images. 
CT vs. 18F-FDG PET for Detecting Preoperative Peritoneal Metastasis
Korean J Radiol 7(4), December 2006 253
A
B
Fig. 3. A 31-year-old man with poorly differentiated adenocarci-
noma of the stomach. 
A. The transverse contrast enhanced CT scan shows multifocal
peritoneal implants in the omentum (arrows). 
B. The transverse CT scan also shows ascitic fluid in the right
paracolic gutter (arrows). The CT reviewers interpreted these
findings as being highly suggestive of peritoneal metastasis. 
C. The PET image does not show significantly increased FDG
uptake in the peritoneal cavity, except for the normal physiologic
colon uptake in the ascending colon. Peritoneal metastasis was
confirmed by laparotomy.
C
Table 2. Az Values and Corresponding Values for Each
Reviewer for the Detection of Peritoneal Metastasis
by Using CT and PET Imaging
CT PET
Respective Az value* Reviewer 1: 0.898 Reviewer 2: 0.858
Reviewer 3: 0.760 Reviewer 4: 0.605
Az value of pooled data 0.878 0.686
values 0.684 0.460
Note. * Data are values for area (Az) under the ROC curve.
Values for CT imaging was significantly higher than that for PET imaging
(p < 0.05)
The values indicate the degree of agreement among the observers.
DISCUSSION
Our present findings, on the basis of analyzing the
original preoperative reports, showed that CT had a higher
sensitivity (76.5% vs 35.3%), a lower specificity (91.6%
vs 98.9%), and an equal accuracy (89.3%) when compared
with the PET imaging. In the clinical setting of peritoneal
carcinomatosis, the higher sensitivity of CT will help
physicians avoid unnecessary surgery in the patients with
peritoneal metastasis. The higher specificity of PET
suggests that PET may be helpful in the equivocal cases on
CT, as this will preclude missing the chance for performing
curative surgery. However, CT imaging also appeared to
be superior to PET imaging when comparing the diagnostic
performance of the two modalities (91.6% vs 71.4%,
respectively). 
Although the role of 18F-FDG PET in the evaluation of
peritoneal metastasis has not yet been established, several
studies have shown promising results. Turlakow et al. have
reported the superior sensitivity of PET to CT for their
patients who had various malignancies, including gastric
malignancy (12). Tanaka et al. have also demonstrated
PET sensitivities far superior to CT for the evaluation of
colorectal tumor peritoneal recurrence (11). The results for
the evaluation of primary serous peritoneal carcinoma or
bile duct cancer appear similarly promising (10, 21).
However, our results suggests that 18F-FDG PET is not
significantly better than CT for the detection of peritoneal
metastasis in the patients with gastric carcinoma, and this
finding stands in contrast to the previous reports (10 12,
21) on patients with various abdominal malignancies. 
Open laparotomy with peritoneal biopsy is the gold
standard for the diagnosis of peritoneal metastasis because
the peritoneum may be assessed visually and it can also be
carefully examined by hand. Although a greater number of
diagnostic biopsies may be performed with open laparo-
tomy and the ascitic fluid easily sampled, this technique is
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Fig. 4. A 72-year-old man with moderately differentiated adenocarcinoma of the
stomach. 
A. Multiple tiny soft tissue infiltrations are suspected in the right paracolic gutter on
the CT image (arrows). The CT reviewers interpreted this finding as being peritoneal
metastasis. 
B. The PET image does not show significantly increased FDG uptake in the
peritoneal cavity. The absence of peritoneal metastasis was identified by laparo-
tomy. 
A
B
Fig. 5. Plot showing the receiver operating characteristic curves
for detecting peritoneal metastasis with using CT (solid line) and
PET (dotted line).
invasive (12). CT remains as the preoperative modality of
choice for the diagnosis of peritoneal metastasis because it
is widely available at most medical centers, less expensive
than the other imaging modalities and less invasive than
surgical procedures. However, so far, peritoneal metastasis
is often detected and confirmed intraoperatively due to the
limited capability of CT (15). Some authors have described
the relatively lower sensitivity (17 54%) on the basis of
their results using conventional CT scanning with a
relatively thick section thickness (5, 7, 22). Metastases can
vary in size and they can be as small as a few millimeters.
If the section thickness exceeds the size of the lesion, then
the lesions may not be optimally seen due to partial
volume averaging. Therefore, with using conventional CT
scanners, it was technically not possible to obtain thin
sections through the relatively large volume of the
abdomen and pelvis. In most studies, 10-mm thick sections
were obtained either contiguously or at 10-mm intervals.
As a result, there was a high false-negative rate for detect-
ing peritoneal metastases in patients. The acquisition of
very thin sections has been made possible by the recent
advances in scanner technology (single or multi-detector
CT). Several reports have suggested that thin sections may
improve the accuracy of CT for detecting peritoneal
metastasis in ovarian cancer (13, 23). The CT examinations
in our study were performed with various CT scanners
(single or multi-detector CT) and with using various section
thicknesses; however, all the section thicknesses were 7
mm or smaller (3 7 mm). Our relatively higher sensitivity
(76.5%) may be a result of the thinner section thickness
rather than those used by the previous published reports
(5, 7, 22). 
There are several well known limitations of PET imaging
that could be associated with the relatively lower sensitiv-
ity or diagnostic performance for the preoperative
detection of peritoneal metastasis in the patients with
gastric cancer. The first is the low spatial resolution of PET
imaging. Because of the physical characteristics of the PET
scanner and specifically the spatial resolution of 4 5 mm
or higher, small seeded peritoneal nodules may be missed
with 18F-PET imaging. Secondly, the 18F-FDG uptake by
gastric cancer shows variable results according to the cell
differentiation. Stahl et al. have reported that mucinous
and signet ring cell carcinomas show significantly lower 18F-
FDG uptake than do the other histologic types of gastric
cancer (24). Yoshioka et al. have reported that poorly
differentiated adenocarcinomas and signet ring cell
carcinomas tend to show low 18F-FDG accumulation in the
primary lesions, and this is probably because of the low
concentration of cancer cells with a lot of stromal tissue, in
spite of their aggressiveness (25). The same problems
might be expected to occur with peritoneal metastasis,
although it is well known that the differentiation of
primary and metastatic gastric cancer lesions can be very
different. In our study, most of the cell differentiation in
the patients with peritoneal metastasis was poor or of the
signet type (13/17). These larger proportions of poor or
signet cell differentiation correspond with the previous
studies showing that diffuse type cancers (poor, signet ring
cell and mucinous differentiation) were more correlated
with peritoneal metastasis, rather than the intestinal type
metastasis (26 28). These cell differentiations might be
related to the lower sensitivity of PET imaging. Third,
there is marked interobserver variability for the physiolog-
ical peritoneal 18F-FDG uptake owing to the differences in
involuntary muscle activity (ex. intestine) (29). In our
study, the values for PET imaging also showed a lower
tendency than those of the CT imaging (PET: 0.460 and
CT: 0.684). Fourth, PET imaging cannot detect ascitic fluid,
which is the most common finding of peritoneal metastasis
and this could easily be detected with CT. 
Our present study contained several significant limita-
tions. First, the study population was small. Further studies
with a larger sample size are needed to statistically confirm
our results. In addition, for the determination of sensitivity,
specificity and accuracy with using the original preopera-
tive reports, we regarded both the definitely identified and
suspected peritoneal metastases as positive cases. This
process may result in statistical error. Second, the cases
that did not undergo surgery or histologic confirmative
examination were excluded from our study. This exclusion
may have resulted in a potentially important source of
selection bias. However, this selection bias cannot be
overcome in the clinical setting. Third, we performed our
analysis on a per-patient basis, rather than on a per-lesion
basis, because we cannot determine the site-by-site correla-
tions of CT, PET and the surgical findings for the depiction
of peritoneal implants. However, the diagnosis of
peritoneal spread is a critical observation and the distribu-
tion of the peritoneal implants is of lesser importance for
most cancers. Forth, this study included CT scans that were
obtained by using a variety of CT techniques (various CT
scanners; single or multi-detector CT scanners or various
section collimation, i.e., 0.75 7 mm). However, our CT
protocol used similar scanning levels, including the entire
abdomen and pelvis, and all the reconstruction thicknesses
were 7 mm or smaller. Finally, our study was performed to
evaluate the accuracy of each CT and PET modality. A
new imaging technique combining PET and CT equipment
has recently been introduced for clinical use. A compara-
tive trial with this combined PET and CT equipment for
the detection of peritoneal metastasis should be
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undertaken.
In conclusion, for the patients with gastric adenocarci-
noma, CT was more sensitive and showed a higher
diagnostic performance than did PET for the detection of
peritoneal metastasis, although CT had a relatively lower
specificity than did PET. Adequate surveillance of
peritoneal metastasis in gastric cancer patients based on
PET alone is not possible. CT remains as the most
important investigative modality for the preoperative
evaluation of peritoneal metastases from gastric cancer. 
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